Author:
Luo Wenting
Author address:
China
Full conference title:
European Academy of Allergy and Clinical Immunology Congress 2019
Date: 20 August 2020
Abstract:
Background
Fungal spores and hyphal fragments in air reportedly cause immunoglobulin E (IgE)-mediated respiratory allergic diseases. However, there is a lack of detailed studies investigating the sensitisation caused by various mycotic allergens and Aspergillus fumigatus components. We analysed the prevalence of fungal allergens in patients in Southern China and discussed sensitization to seven fungal allergens in patients with respiratory allergic diseases. We also analysed roles of Aspergillus components in the differential diagnosis of ABPA and asthma.
Method
In total, 4033 patients with respiratory diseases were enrolled in this study to analyze the prevalence of aspergillus fumigatus. SIgE against to Aspergillus fumigatus, Penicillium chrysogenum, Cladosporium herbarum, Mucor racemosus, Candida albicans, Alternaria alternata, and Helminthosporium halodes were further tested. The role of Aspergillus fumigatus components in the differential diagnosis of ABPA and asthma was investigated.
Results
Among 4033 patients, 7.30% were positive for Aspergillus fumigatus allergen-sIgE, with an median sIgE level of 1.10 (0.54-3.79) kU/L. Notably, Aspergillus fumigatus accounted for 21.8% of all fungus-positive cases. The six fungi had high positivity rates in co-sensitization to Aspergillus fumigatus (84.6-100%). Aspergillus fumigatus was correlated with all other fungi (0.51-0.82,). The correlation between Aspergillus fumigatus and Asp f 2 was the strongest (r = 0.73). The positivity rate and sIgE level of Asp f 6 were significantly higher in patients with ABPA than in patients with asthma (P < 0.05, table 1).
Conclusion
Overall, these findings showed that fungi had important sensitizing effects in patients with asthma and ABPA. Asp f 6 measurement may facilitate the differential diagnosis of ABPA and asthma.
|
ABPA (n = 18) |
AS (n = 30) |
||
|
Positive rate n (%) |
sIgE level (kU/L) median (interquartile) |
Positive rate n (%) |
sIgE level (kU/L), median (interquartile) |
Asp f 1 |
16 (88.9) |
7.93 (1.40-30.18) |
22 (73.3) |
1.21 (0.24-10.65) |
Asp f 2 |
12 (66.7) |
3.46 (0.08-9.10) |
15 (50.0) |
0.35 (0.03-3.00) |
Asp f 3 |
12 (66.7) |
0.83 (0.07-11.53) |
18 (60.0) |
1.03 (0.04-4.62) |
Asp f 4 |
11 (61.1) |
3.20 (0.10-17.65) |
14 (46.7) |
0.21 (0.02-12.93) |
Asp f 6 |
12 (66.7)* |
1.22 (0.07-5.70)† |
8 (26.7) |
0.03 (0.01-0.61) |
Abstract Number: TP1508
Link to conference website:
Link Conference abstract:
Conference abstracts, posters & presentations
-
Title
Author
Year
Number
Poster
-
v
Teclegiorgis Gebremariam [MS]1, Yiyou Gu [PhD]1, Sondus Alkhazraji [PhD]1, Jousha Quran1, Laura K. Najvar [BS]2, Nathan P. Wiederhold [PharmD]2, Thomas F. Patterson [MD]2, Scott G. Filler [MD]1,3, David A. Angulo (MD)4, Ashraf S. Ibrahim [PhD]1,3*,
2024
91
n/a
-
v
Ruta Petraitiene (US)
2024
90
n/a
-
v
Fabio Palmieri (CH), Junier Pilar
2024
89
n/a
-
v
Evelyne Côté (CA)
2024
88
n/a
-
v
Eliane Vanhoffelen (BE)
2024
87
n/a
-
v
Teclegiorgis Gebremariam, Yiyou Gu, Eman Youssef, Sondus Alkhazraji, Joshua Quran, Nathan P. Wiederhold, Ashraf S. Ibrahim
2024
86
n/a
-
v
Thomas Orasch (DE)
2024
85
n/a
-
v
Julien Alex, Katherine González, Gauri Gangapurwala, Antje Vollrath, Zoltán Cseresnyés, Christine Weber, Justyna A. Czaplewska, Stephanie Hoeppener, Carl-Magnus Svensson, Thomas Orasch, Thorsten Heinekamp, Carlos Guerrero-Sánchez, Marc Thilo Figge, Ulrich S. Schubert, Axel A. Brakhage
2024
84
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
83
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
82
n/a